Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

A Knowledge-Based Approach for Identification of Drugs Against Vivapain-2 Protein of Plasmodium vivax Through Pharmacophore-Based Virtual Screening with Comparative Modelling.

Yadav MK, Singh A, Swati D.

Appl Biochem Biotechnol. 2014 Aug;173(8):2174-88. doi: 10.1007/s12010-014-1023-y. Epub 2014 Jun 27.

PMID:
24970047
[PubMed - in process]
2.
3.

Identification and biochemical characterization of vivapains, cysteine proteases of the malaria parasite Plasmodium vivax.

Na BK, Shenai BR, Sijwali PS, Choe Y, Pandey KC, Singh A, Craik CS, Rosenthal PJ.

Biochem J. 2004 Mar 1;378(Pt 2):529-38.

PMID:
14629194
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.

Bouillon A, Giganti D, Benedet C, Gorgette O, Pêtres S, Crublet E, Girard-Blanc C, Witkowski B, Ménard D, Nilges M, Mercereau-Puijalon O, Stoven V, Barale JC.

J Biol Chem. 2013 Jun 21;288(25):18561-73. doi: 10.1074/jbc.M113.456764. Epub 2013 May 7.

PMID:
23653352
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.

Kesharwani RK, Singh DV, Misra K.

J Vector Borne Dis. 2013 Apr-Jun;50(2):93-102.

PMID:
23995310
[PubMed - indexed for MEDLINE]
6.

Drug target prioritization in Plasmodium falciparum through metabolic network analysis, and inhibitor designing using virtual screening and docking approach.

Yadav MK, Pandey SK, Swati D.

J Bioinform Comput Biol. 2013 Aug;11(4):1350003. doi: 10.1142/S0219720013500030. Epub 2013 Feb 25.

PMID:
23859267
[PubMed - indexed for MEDLINE]
7.

Biochemical properties of a novel cysteine protease of Plasmodium vivax, vivapain-4.

Na BK, Bae YA, Zo YG, Choe Y, Kim SH, Desai PV, Avery MA, Craik CS, Kim TS, Rosenthal PJ, Kong Y.

PLoS Negl Trop Dis. 2010 Oct 12;4(10):e849. doi: 10.1371/journal.pntd.0000849.

PMID:
20967286
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A combination of receptor-based pharmacophore modeling & QM techniques for identification of human chymase inhibitors.

Arooj M, Sakkiah S, Kim S, Arulalapperumal V, Lee KW.

PLoS One. 2013 Apr 26;8(4):e63030. doi: 10.1371/journal.pone.0063030. Print 2013.

PMID:
23658661
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Mechanistic insights into mode of action of novel natural cathepsin L inhibitors.

Tyagi C, Grover S, Dhanjal J, Goyal S, Goyal M, Grover A.

BMC Genomics. 2013;14 Suppl 8:S10. doi: 10.1186/1471-2164-14-S8-S10. Epub 2013 Dec 9.

PMID:
24564425
[PubMed - in process]
Free PMC Article
10.

Sequence homology and structural analysis of plasmepsin 4 isolated from Indian Plasmodium vivax isolates.

Rawat M, Vijay S, Gupta Y, Dixit R, Tiwari PK, Sharma A.

Infect Genet Evol. 2011 Jul;11(5):924-33. doi: 10.1016/j.meegid.2011.02.024. Epub 2011 Mar 5.

PMID:
21382523
[PubMed - indexed for MEDLINE]
11.

Centenary celebrations article: Cysteine proteases of human malaria parasites.

Pandey KC.

J Parasit Dis. 2011 Oct;35(2):94-103. Epub 2011 Dec 3.

PMID:
23024488
[PubMed]
Free PMC Article
12.

Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.

Kasam V, Zimmermann M, Maass A, Schwichtenberg H, Wolf A, Jacq N, Breton V, Hofmann-Apitius M.

J Chem Inf Model. 2007 Sep-Oct;47(5):1818-28. Epub 2007 Aug 30.

PMID:
17727268
[PubMed - indexed for MEDLINE]
13.

Evaluation of cysteine proteases of Plasmodium vivax as antimalarial drug targets: sequence analysis and sensitivity to cysteine protease inhibitors.

Na BK, Kim TS, Rosenthal PJ, Lee JK, Kong Y.

Parasitol Res. 2004 Oct;94(4):312-7. Epub 2004 Sep 15.

PMID:
15372231
[PubMed - indexed for MEDLINE]
14.

Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies.

Penna-Coutinho J, Cortopassi WA, Oliveira AA, França TC, Krettli AU.

PLoS One. 2011;6(7):e21237. doi: 10.1371/journal.pone.0021237. Epub 2011 Jul 14.

PMID:
21779323
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Potent BACE-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies.

John S, Thangapandian S, Sakkiah S, Lee KW.

BMC Bioinformatics. 2011 Feb 15;12 Suppl 1:S28. doi: 10.1186/1471-2105-12-S1-S28.

PMID:
21342558
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Ligand-based pharmacophore modelling and screening of DNA minor groove binders targeting Staphylococcus aureus.

Vijayalakshmi P, Selvaraj C, Shafreen RM, Singh SK, Pandian SK, Daisy P.

J Mol Recognit. 2014 Jul;27(7):429-37. doi: 10.1002/jmr.2363.

PMID:
24895275
[PubMed - in process]
17.

Metabolic pathway analysis and molecular docking analysis for identification of putative drug targets in Toxoplasma gondii: novel approach.

Gautam B, Singh G, Wadhwa G, Farmer R, Singh S, Singh AK, Jain PA, Yadav PK.

Bioinformation. 2012;8(3):134-41. Epub 2012 Feb 3.

PMID:
22368385
[PubMed]
Free PMC Article
18.

Pharmacoinformatics elucidation of potential drug targets against migraine to target ion channel protein KCNK18.

Sehgal SA, Hassan M, Rashid S.

Drug Des Devel Ther. 2014 May 21;8:571-81. doi: 10.2147/DDDT.S63096. eCollection 2014.

PMID:
24899801
[PubMed - in process]
Free PMC Article
19.

PDTD: a web-accessible protein database for drug target identification.

Gao Z, Li H, Zhang H, Liu X, Kang L, Luo X, Zhu W, Chen K, Wang X, Jiang H.

BMC Bioinformatics. 2008 Feb 19;9:104. doi: 10.1186/1471-2105-9-104.

PMID:
18282303
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors.

Vyas VK, Ghate M, Goel A.

J Mol Graph Model. 2013 May;42:17-25. doi: 10.1016/j.jmgm.2013.01.010. Epub 2013 Feb 24.

PMID:
23507201
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk